China Merchants Group leads $78m funding in Gmax Biopharm International

China Merchants Group leads $78m funding in Gmax Biopharm International

Source: Volodymyr Hryshchenko/Unsplash

Clinical-stage biopharmaceutical firm Gmax Biopharm International Limited has secured $78 million in a Series C round funding led by state-backed conglomerate China Merchants Group, the investee said in a WeChat post.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter